4//SEC Filing
Flores Osvaldo 4
Accession 0001062993-23-002312
CIK 0001850119other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:52 PM ET
Size
7.2 KB
Accession
0001062993-23-002312
Insider Transaction Report
Form 4
Flores Osvaldo
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-02+637,500→ 637,500 totalExercise: $4.64Exp: 2033-02-02→ Common Stock (637,500 underlying) - Award
Stock Option (right to buy)
2023-02-02+637,500→ 637,500 totalExercise: $4.64Exp: 2033-02-02→ Common Stock (637,500 underlying)
Footnotes (1)
- [F1]The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001867301
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:52 PM ET
- Size
- 7.2 KB